AF
BBIO icon

Advisornet Financial’s BridgeBio Pharma BBIO Stock Holding History

Advisornet Financial’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.3K Sell
501
-1
-0.2% -$70 ﹤0.01% 1215
2026
Q1 		$37.3K Buy
502
+32
+7% +$2.32K ﹤0.01% 1148
2025
Q4 		$36K Buy
470
+56
+14% +$3.68K ﹤0.01% 1161
2025
Q3 		$21.5K Buy
414
+51
+14% +$2.49K ﹤0.01% 1280
2025
Q2 		$15.7K Buy
363
+20
+6% +$727 ﹤0.01% 1353
2025
Q1 		$11.9K Buy
343
+336
+4,800% +$11.3K ﹤0.01% 1356
2024
Q4 		$192 Hold
7
– – ﹤0.01% 1883
2024
Q3 		$178 Buy
+7
New +$184 ﹤0.01% 2129
2024
Q1 		– Sell
-22
Closed -$888 – 2088
2023
Q4 		$888 Buy
22
+4
+22% +$120 ﹤0.01% 1915
2023
Q3 		$475 Buy
18
+6
+50% +$170 ﹤0.01% 1995
2023
Q2 		$206 Buy
12
+4
+50% +$60 ﹤0.01% 2215
2023
Q1 		$133 Buy
8
+1
+14% +$12 ﹤0.01% 2293
2022
Q4 		$53 Buy
+7
New +$67 ﹤0.01% 2328

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Advisornet Financial's BBIO Position: Q2 2026 in Review

Advisornet Financial reduced its BridgeBio Pharma (BBIO) stake by 0.2% in Q2 2026, selling an estimated $70 and leaving 501 shares worth $37.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Advisornet Financial first reported a position in BBIO in Q4 2022 and has held it in 13 quarters since. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Advisornet Financial held 501 shares of BridgeBio Pharma worth $37.3K as of Q2 2026.
  • Advisornet Financial sold 1 BridgeBio Pharma share in Q2 2026, an estimated $70.
  • BridgeBio Pharma made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1215 holding.
  • Advisornet Financial first reported a position in BridgeBio Pharma in Q4 2022 and has held it in 13 quarters since.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.